RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies Kumar Jeetendra | January 13, 2021 LANGENFELD, Germany – 13. January 2021 – Life Science Newswire – RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, announced it has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization. This marks a landmark achievement for RheinCell, which is now among a …
Top Benefits of Stem Cell Therapy for Chronic Pain Management Kumar Jeetendra | March 15, 2024 Some potential benefits have emerged from the availability of stem cell therapy for the treatment of chronic pain. Here are a few of the more notable advantages: Healing and Regeneration of inured tissue: First, stem cells can differentiate into many different kinds of cells, which aid in the healing and regeneration of injured tissues. By …
Cell Therapy manufacturing challenges Kumar Jeetendra | July 8, 2024 Cell therapy is a medical breakthrough in addressing various illnesses such as cancer, genetic disorders and immune system related diseases. However, the translation of these therapies from lab to clinical and commercial settings is obstructed by significant manufacturing challenges. This article covers the complexities of cell therapy manufacturing, highlighting some major technical, regulatory and logistical …
